Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance

DexCom, Inc.Trade
Schwab US Dividend Equity ETFTrade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Schwab US Dividend Equity ETF — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while Schwab US Dividend Equity ETF trades at $34.24. Which is the better fit depends on your goals.

DXCMSCHD
Market Cap
$33.08B
Sector
HealthBroad Market / Factor
52-Week High
$89.53$34.27
52-Week Low
$54.84$26.44
Enterprise Value
$32.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

No Aura AI signal available yet.

Schwab US Dividend Equity ETF

SCHD, the Schwab U.S. Dividend Equity ETF, trades at $33.90, up 0.59% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF focuses on high-quality U.S. dividend-paying stocks, offering income stability. Recent news highlights its popularity among retirees for generating passive income, with institutional buying activity noted in Q2 2026 filings.

The outlook for SCHD remains positive for income-focused investors, leveraging dividend growth and low costs. Risks include interest rate sensitivity and market volatility affecting dividend stocks. Analyst sentiment is generally favorable, emphasizing its role in diversified retirement portfolios.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD